Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

RNA-Seq Analysis of Clonal Hematopoiesis (CHIP) Blood Leukocytes Shows Dysregulation of Neutrophil / Innate Immunity-Related Genes

Elina K Cook, MSc, Richard N Armstrong, PhD, Eshita Sharma, PhD, Brooke Snetsinger, MSc, Jacqueline Boultwood, PhD, Rena Buckstein, MD FRCPC, Andrea Pellagatti, PhD, Michael J. Rauh, MD PhD

Blood (2018) 132 (Supplement 1): 3843.

https://doi.org/10.1182/blood-2018-99-116128

Published: 2018

Journal Articles

Proteome Analyses and Single-Cell RNA Sequencing Reveal Age-Dependent Re-Wiring of Central Carbon Metabolism in Myeloid-Biased Subsets of Human Hematopoietic Stem Cells

Marco L Hennrich, PhD, Natalie Romanov, Patrick Horn, PhD, Samira Jaeger, PhD, Volker Eckstein, PhD, Laura Poisa-Beiro, PhD, Jacqueline Boultwood, PhD, Thomas Luft, MD PhD, Andrea Pellagatti, PhD, Peer Bork, PhD, Patrick Aloy, PhD, Anne-Claude Gavin, PhD, Anthony D. Ho, MD FRCPC

Blood (2018) 132 (Supplement 1): 873.

https://doi.org/10.1182/blood-2018-99-110787

Published: 2018

Journal Articles

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Blood (2018) 132 (Supplement 1): 4347.

https://doi.org/10.1182/blood-2018-99-112062

Published: 2018

Journal Articles

Comparison of Two Different Therapeutic Regimens with Azacitidine and Lenalidomide (Combined versus Sequential) in Higher-Risk Myelodysplastic Syndromes. Update of Long-Term Results of a Randomized Phase II Multicenter Study

Blood (2018) 132 (Supplement 1): 4365.

https://doi.org/10.1182/blood-2018-99-117714

Published: 2018

Journal Articles

SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition

Blood (2018) 132 (Supplement 1): 107.

https://doi.org/10.1182/blood-2018-99-118747

Published: 2018

Journal Articles

De Novo UBE2A Mutations Are Recurrently Acquired during CML Progression and Interfere with Myeloid Differentiation Pathways

Blood (2017) 130 (Supplement 1): 44.

https://doi.org/10.1182/blood.V130.Suppl_1.44.44

Published: 2017

Journal Articles

Splicesome Mutant MDS and AML Cells Activate Innate Immune Signaling By Regulating the Expression of Therapeutically Targetable IRAK4 Isoforms

Molly A Smith, Gaurav Choudhary, PhD, Andrea Pellagatti, PhD, Kwangmin Choi, PhD, Tushar Damodar Bhagat, PhD, Nathan Salomonis, PhD, Matthew J. Walter, MD, Kakajan Komurov, Maria Elena S Sampson, Shanisha Gordon, Dagny Von Ahrens, Kith Pradhan, PhD, Ulrich G. Steidl, MDPhD, Robert Booher, PhD, Jacqueline Boultwood, PhD, Amit Verma, MD, Daniel Starczynowski, PhD

Blood (2017) 130 (Supplement 1): 785.

https://doi.org/10.1182/blood.V130.Suppl_1.785.785

Published: 2017

Journal Articles

Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function

Blood (2017) 130 (Supplement 1): 2497.

https://doi.org/10.1182/blood.V130.Suppl_1.2497.2497

Published: 2017

Journal Articles

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Y Follo, PhD, Andrea Pellagatti, PhD, Richard N Armstrong, PhD, Stefano Ratti, MD, Sara Mongiorgi, PhD, Annalisa Astolfi, PhD, Valentina Indio, PhD, Cristina Clissa, MD PhD, Domenico Russo, MD, Marco Gobbi, MD, Marilena Barraco, PhD, Sarah Parisi, MD PhD, Andrea Pession, MD, Michele Cavo, MD, Lucia Manzoli, MD, Lucio Cocco, MD, Jacqueline Boultwood, PhD, Carlo Finelli, MD

Blood (2017) 130 (Supplement 1): 5299.

https://doi.org/10.1182/blood.V130.Suppl_1.5299.5299

Published: 2017

Journal Articles

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

Blood (2016) 128 (22): 4314.

https://doi.org/10.1182/blood.V128.22.4314.4314

Published: 2016

Journal Articles

Molecular and Clinical Characterization of Patients with Myeloid Neoplasms Carrying the 12p Deletion

Vera Adema, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Andrea Pellagatti, PhD, Jacqueline Boultwood, PhD, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Francesc Sole, PhD, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 2007.

https://doi.org/10.1182/blood.V128.22.2007.2007

Published: 2016

Journal Articles

Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia

Yusuke Shiozawa, MD, Luca Malcovati, MD, Anna Gallì, Andrea Pellagatti, PhD, Hiromichi Suzuki, MD PhD, Tetsuichi Yoshizato, MD PhD, Yusuke Sato, MD PhD, Keisuke Kataoka, MD PhD, Kenichi Yoshida, MD PhD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Hideki Makishima, MD PhD FACP, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Satoru Miyano, PhD, Jacqueline Boultwood, PhD, Eva Hellström-Lindberg, MD PhD, Seishi Ogawa, MD PhD, Mario Cazzola, MD

Blood (2016) 128 (22): 1974.

https://doi.org/10.1182/blood.V128.22.1974.1974

Published: 2016

Journal Articles

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Christian Scharenberg, MD, Petter S. Woll, PhD, Valentina Giai, MD PhD, Andrea Pellagatti, PhD, Leonie Saft, MD PhD, Marios Dimitriou, Martin Jädersten, Monika Jansson, Iyadh Douagi, PhD, Donna S. Neuberg, ScD, Mohsen Karimi, Katarina Le Blanc, MD, PhD, Jacqueline Boultwood, PhD, Sten Eirik Jacobsen, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2016) 128 (22): 4329.

https://doi.org/10.1182/blood.V128.22.4329.4329

Published: 2016

Journal Articles

Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee

Blood (2015) 126 (23): 907.

https://doi.org/10.1182/blood.V126.23.907.907

Published: 2015

Journal Articles

An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML

Blood (2015) 126 (23): 710.

https://doi.org/10.1182/blood.V126.23.710.710

Published: 2015

Journal Articles

Lineage-Specific Aberrant mRNA Splicing By U2AF1 Mutation Alters Erythroid and Granulomonocytic Differentiation

Bon Ham Yip, PhD, Swagata Roy, PhD, Hamid Dolatshad, PhD, Jacqueline Shaw, Seishi Ogawa, MD PhD, Andrea Pellagatti, PhD, Jacqueline Boultwood, PhD

Blood (2015) 126 (23): 142.

https://doi.org/10.1182/blood.V126.23.142.142

Published: 2015

Journal Articles

Targeted Re-Sequencing Analysis of 31 Genes Commonly Mutated in Myeloid Disorders in Serial Samples from Myelodysplastic Syndrome Patients with Disease Progression

Andrea Pellagatti, Cristina Di Genua, Swagata Roy, Adam Burns, BSc, Kathy L McGraw, PhD, Maria José Larrayoz, Marta Fernandez-Mercado, Simona Valletta, Joanne Mason, PhD, Sally Killick, Cristina Mecucci, MD PhD, Maria José Calasanz, Alan F. List, MD, Anna Schuh, MDPhD, Jacqueline Boultwood, PhD

Blood (2014) 124 (21): 1901.

https://doi.org/10.1182/blood.V124.21.1901.1901

Published: 2014

Journal Articles

Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients

Blood (2014) 124 (21): 4601.

https://doi.org/10.1182/blood.V124.21.4601.4601

Published: 2014

Journal Articles

Analysis of Clonal Hierarchy Shows That Other Ancestral Events May Precede Evolution of Del(5q) in Myeloid Neoplasms

Naoko Hosono, MD PhD, Hideki Makishima, MD PhD, Bartlomiej P Przychodzen, Thomas LaFramboise, PhD, Chantana Polprasert, MD, Michael J. Clemente, Jacqueline Boultwood, PhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2014) 124 (21): 4605.

https://doi.org/10.1182/blood.V124.21.4605.4605

Published: 2014

Journal Articles

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Aditi Shastri, MD, Carolina Schinke, MD, Asya Varshavsky Yanovsky, MD PhD, Tushar D. Bhagat, PhD, Orsolya Giricz, Laura Barreyro, M.Sc., Jacqueline Boultwood, PhD, Andrea Pellagati, Yiting Yu, PhD, Jennifer R. Brown, MD PhD, David A. Frank, MD PhD, Bhaskar Das, PhD, Suman Kambhampati, MD, Britta Will, PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 3602.

https://doi.org/10.1182/blood.V124.21.3602.3602

Published: 2014

NARROW

RNA-Seq Analysis of Clonal Hematopoiesis (CHIP) Blood Leukocytes Shows Dysregulation of Neutrophil / Innate Immunity-Related Genes

Proteome Analyses and Single-Cell RNA Sequencing Reveal Age-Dependent Re-Wiring of Central Carbon Metabolism in Myeloid-Biased Subsets of Human Hematopoietic Stem Cells

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Comparison of Two Different Therapeutic Regimens with Azacitidine and Lenalidomide (Combined versus Sequential) in Higher-Risk Myelodysplastic Syndromes. Update of Long-Term Results of a Randomized Phase II Multicenter Study

SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition

De Novo UBE2A Mutations Are Recurrently Acquired during CML Progression and Interfere with Myeloid Differentiation Pathways

Splicesome Mutant MDS and AML Cells Activate Innate Immune Signaling By Regulating the Expression of Therapeutically Targetable IRAK4 Isoforms

Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

Molecular and Clinical Characterization of Patients with Myeloid Neoplasms Carrying the 12p Deletion

Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee

An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML

Lineage-Specific Aberrant mRNA Splicing By U2AF1 Mutation Alters Erythroid and Granulomonocytic Differentiation

Targeted Re-Sequencing Analysis of 31 Genes Commonly Mutated in Myeloid Disorders in Serial Samples from Myelodysplastic Syndrome Patients with Disease Progression

Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients

Analysis of Clonal Hierarchy Shows That Other Ancestral Events May Precede Evolution of Del(5q) in Myeloid Neoplasms

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only